KRKNF yields 34.78% · MRK yields 2.76%● Live data
📍 KRKNF pulled ahead of the other in Year 1
Combined, KRKNF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of KRKNF + MRK for your $10,000?
Kraken Robotics Inc., a marine technology company, engages in the design, manufacture, and sale of software-centric sensors, batteries, and underwater robotic systems for unmanned underwater vehicles used in military and commercial applications. It operates in two segments, Sensors and Platforms, and Power. The company offers AquaPix Miniature interferometric synthetic aperture sonar (MINSAS), a configurable MINSAS; and SeaVision, an underwater laser imaging system. It also provides Kraken Active Towed Fish (KATFISH), a towed underwater vehicle for high speed and high resolution seabed mapping; ThunderFish, an autonomous underwater vehicle; and ALARS, an autonomous launch and recovery system that enable an unmanned vehicle and its payloads to be brought aboard to a host ship. In addition, the company designs and manufactures pressure tolerant thrusters, drives, batteries, battery management systems, and electronics; and robotics as a service, as well as implements digital signal processing and user interface software for anti-submarine warfare sonar applications. It has operations in Canada, the United States, Europe, and internationally. The company was formerly known as Kraken Sonar Inc. and changed its name to Kraken Robotics Inc. in September 2017. Kraken Robotics Inc. is headquartered in Mount Pearl, Canada.
Full KRKNF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.